16 March 2022 | Antibody decay, T cell immunity and breakthrough infections following two SARS-CoV-2 vaccine doses in inflammatory bowel disease patients treated with infliximab and vedolizumab
| Lin, S; Kennedy, NA; Saifuddin, A; et al. |
27 September 2016 | Ethical issues and best practice in clinically based genomic research: Exeter Stakeholders Meeting Report
| Carrieri, D; Bewshea, C; Walker, G; et al. |
23 September 2018 | Ethical issues in genomic research: Proposing guiding principles co-produced with stakeholders
| Carrieri, D; Jackson, L; Bewshea, C; et al. |
16 April 2024 | Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study
| Chanchlani, N; Lin, S; Bewshea, C; et al. |
27 February 2019 | Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study
| Kennedy, NA; Heap, GA; Green, HD; et al. |
15 May 2023 | Pretreatment Vitamin D Concentrations Do Not Predict Therapeutic Outcome to Anti-TNF Therapies in Biologic-Naïve Patients With Active Luminal Crohn's Disease
| Chanchlani, N; Lin, S; Smith, R; et al. |